Institut Regional du Cancer de Montpellier

Recent papers from Institut Regional du Cancer de Montpellier

1. Treatment outcomes of tucatinib in combination with trastuzumab and pertuzumab as a maintenance therapy for people with HER2+ metastatic breast cancer: a plain language summary of findings from HER2CLIMB-05Future Oncology · 2026
2. An Aliquoting Strategy for Commercial Gallium-68 Radiopharmaceutical Cold Kits.2026
3. The Pregnane X Receptor (PXR) contributes to phenotypic plasticity and modulates the sensitivity to targeted therapies in melanoma2026
4. Pretherapeutic Tumor Growth Velocity Refines Survival Stratification Beyond Clinical, Molecular, and Surgical Factors in IDH-Mutant Lower-Grade GliomasNeuro-Oncology · 2026
5. Efficacy and safety of pembrolizumab–lenvatinib in metastatic endometrial cancer: results from the French multicenter early access programESMO Open · 2026
6. Tucatinib, trastuzumab, and capecitabine as second- or third-line therapy after trastuzumab deruxtecan in HER2-positive metastatic breast cancer: A multicenter retrospective study in FranceThe Breast · 2026
7. Enniatin B attenuates deoxynivalenol-induced toxicity in liver cells and modulates lipid metabolism-related pathwaysEnvironment International · 2026
8. Treatment patterns and outcomes in advanced and metastatic lung cancer in France: Results from the Epidemiological Strategy and medical Economics (ESME) database lung cancer in FranceLung Cancer · 2026
9. Antiangiogenic therapies in gastric cancer: future directions for 2026 and beyond: an UNICANCER gastrointestinal group (UCGI) perspectiveCancer Treatment Reviews · 2026
10. When effective anticancer therapies are, in fact, destabilizing the tumor’s Group Phenotypic Compositionnpj Precision Oncology · 2026
11. International practice patterns and perceptions of pressurised intraperitoneal aerosol chemotherapy for management of gastric cancer: A global clinician surveyEuropean Journal of Surgical Oncology · 2026
12. Statistical models to characterize colon tumor stiffness heterogeneity through representative atomic force microscopy mapsScientific Reports · 2026
13. Process-Related Incidents in Nuclear Medicine: A Four-Year Single-Center Retrospective Analysis to Support the Implementation of a Scenario-Based Radiopharmacy TrainingPharmacy · 2026
14. Mechanistic Insights of BPA Alternatives on PPARγ Binding and the Consequence on Adipocyte DifferentiationEnvironmental Science & Technology · 2026
15. The clinical benefit of a near complete cytoreduction in patients with colorectal peritoneal metastases: a propensity score matched studyEuropean Journal of Surgical Oncology · 2026
16. HER2CLIMB-05: A Phase 3 Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-line Maintenance Therapy for HER2+ Metastatic Breast CancerJournal of Clinical Oncology · 2025
17. Beyond proof-of-concept: Validating robust automated diffuse lower-grade glioma segmentation for clinical applications in longitudinal follow-upNeuro-Oncology Advances · 2025
18. Circulating Microclots Are Structurally Associated With Neutrophil Extracellular Traps and Their Amounts Are Elevated in Long COVID PatientsJournal of Medical Virology · 2025
19. Tailored Reaction Conditions and Automated Radiolabeling of [177Lu]Lu-PSMA-ALB-56 in a 68Ga Setting: The Critical Impact of Antioxidant ConcentrationsInternational Journal of Molecular Sciences · 2025
20. Targeting SUV4-20H Epigenetic Enzymes Enhances Topoisomerase II Poisoning in Prostate CancerCancer Research · 2025